Anti-infective Drugs Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

The anti-infective drugs market is segmented by product type (antibiotics, antivirals, antifungals, and other products), indication, distribution channel, and geography.

Market Snapshot

Anti-infective Drugs Market Image 1
Study Period: 2018 - 2026
Base Year: 2020
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 3.5 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

Anti-infectives drugs has been one of the major segment for many pharmaceutical companies from decades. Over the past two decades, the infection rate has grown significantly, particularly across the low and middle income countries. 

There are a large number of companies well-established in the market with their products in the form of antifungals, antibiotics, anti-bacterial, anti-protozoans and antivirals targeting cytochrome, interleukin, interferons and some are multi-drug resistants. The primary driving factor for the growth of the market is increasing burden of several infectious diseases across developed and emerging markets such as different forms of influenza, diarrhea, hepatitis, and urinary tract infections, among others, which needs more attention from pharmaceutical and biotechnology companies. 

Moreover, there has been significant growth in the number of multidrug-resistant organisms across several parts of the world, which further increases the importance of innovation in the anti-infective agents.

However, some of the major restraints to this market are high investment costs in R&D, as major importance is given to multi-drug resistant drug, where several companies product fail in the early-stage or clinical stage of development. Also, shortage of resources in healthcare facilities particularly in emerging markets, restricts the growth of this market.

Scope of the Report

The anti-infective drugs/agents are described as substances which prevent infectious agents or organisms from spreading. These are mostly communicable diseases spread from viruses, bacteria, fungi, and other organisms. There are several global players having well-establsihed R&D with increased focus upon development of innovative drugs agaisnt multidrug resistant organisms. The scope of thi market is segmented by product type, indication, distribution channel, and geography.

By Product Type
Antibiotics
Antivirals
Antifungals
Other Products
By Indication
HIV Infection
Pneumonia
Respiratory Virus Infection
Sepsis
Tuberculosis
Other Indications
By Distribution Channel
Hospital Pharmacy
Retail Pharmacy
Other Distribution Channels
Geography
North America
United States
Canada
Mexico
Europe
France
Germany
United Kingdom
Italy
Spain
Rest of Europe
Asia Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa
GCC
South Africa
Rest of Middle East and Africa
South America
Brazil
Argentina
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

Antiviral Products are Expected to Register High Growth Over the Forecast Period

  • The anti-viral agents are expected to show high growth over the forecast period, as several drug manufacturers are exploring the opportunities to expand in the lower and middle income countries, where epidemic infection rate is high. 
  • There is high diversity in patient pool which require long treatment procedures in hospital facilities as well as home care treatments. 
  • Moreover, there has been observed a growing interest by government in countries showing fast economic growth, to collaborate with hospitals and global pharmaceutical companies to imporve the distribution rate of antiviral agents to the needful in the required area of a country. Such factors are expected to boost the growth of antivirals segment over the forecast period.
Anti-infective drugs market trend.png

North America is Estimated to Have Largest Share Over the Forecast Period

With a sophisticated healthcare infrastructure, high awareness in the society, well-established distribution channels and good presence of e-commerce across the United States and Canada drives, helps North America to dominate this market over the forecast period. 

The high purchasing power by the end consumer and favorable reimbursement policies helps pharmaceutical companies to grow in this region. Further, it helps the pharmacetical companies increase the production capabilities, invest more upon the funded projects with renowned medical institutions to suffice the demand of anti-infective drugs across North America.

Anti-infective Drugs Market - Growth Rate by Region

Competitive Landscape

The major market players are focusing on better distribution channel as well as reaching out to each category of patients with different diseases and age groups, which makes the companies grow in this market. Some of the major players in the market are Novartis AG, Merck & Co., Inc, Sanofi SA, GSK, and Gilead Sciences, among others.

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Growing Prevalence of Targeted Diseases

      2. 4.2.2 Growing Initiatives for the Awareness of Infectious Diseases

      3. 4.2.3 Increasing Investments on R&D Activities of Anti-Infective Drugs

    3. 4.3 Market Restraints

      1. 4.3.1 Emergence of Anti-infective Drugs Resistance and Side Effects Associated with Anti-infective drugs

      2. 4.3.2 Shortage of Resources in Certain Low- and Middle-income Countries (LMIC)

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Product Type

      1. 5.1.1 Antibiotics

      2. 5.1.2 Antivirals

      3. 5.1.3 Antifungals

      4. 5.1.4 Other Products

    2. 5.2 By Indication

      1. 5.2.1 HIV Infection

      2. 5.2.2 Pneumonia

      3. 5.2.3 Respiratory Virus Infection

      4. 5.2.4 Sepsis

      5. 5.2.5 Tuberculosis

      6. 5.2.6 Other Indications

    3. 5.3 By Distribution Channel

      1. 5.3.1 Hospital Pharmacy

      2. 5.3.2 Retail Pharmacy

      3. 5.3.3 Other Distribution Channels

    4. 5.4 Geography

      1. 5.4.1 North America

        1. 5.4.1.1 United States

        2. 5.4.1.2 Canada

        3. 5.4.1.3 Mexico

      2. 5.4.2 Europe

        1. 5.4.2.1 France

        2. 5.4.2.2 Germany

        3. 5.4.2.3 United Kingdom

        4. 5.4.2.4 Italy

        5. 5.4.2.5 Spain

        6. 5.4.2.6 Rest of Europe

      3. 5.4.3 Asia Pacific

        1. 5.4.3.1 China

        2. 5.4.3.2 Japan

        3. 5.4.3.3 India

        4. 5.4.3.4 Australia

        5. 5.4.3.5 South Korea

        6. 5.4.3.6 Rest of Asia-Pacific

      4. 5.4.4 Middle East and Africa

        1. 5.4.4.1 GCC

        2. 5.4.4.2 South Africa

        3. 5.4.4.3 Rest of Middle East and Africa

      5. 5.4.5 South America

        1. 5.4.5.1 Brazil

        2. 5.4.5.2 Argentina

        3. 5.4.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Abbott Laboratories

      2. 6.1.2 Astellas Pharma Inc

      3. 6.1.3 Bayer AG

      4. 6.1.4 Bristol-Myers Squibb Company

      5. 6.1.5 Gilead Sciences, Inc

      6. 6.1.6 GlaxoSmithKline PLC

      7. 6.1.7 Merck & Co., Inc.

      8. 6.1.8 Novartis AG

      9. 6.1.9 Pfizer, Inc

      10. 6.1.10 Sanofi SA

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Anti-infective Drugs Market market is studied from 2018 - 2026.

The Anti-infective Drugs Market is growing at a CAGR of 3.5% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2020.

Merck & Co., Inc, Gilead Sciences, GlaxoSmithKline PLC, Pfizer Inc, Novartis AG are the major companies operating in Anti-infective Drugs Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!